In this episode, Steven M. Horwitz, MD; Francine Foss, MD; and Barbara Pro, MD, answer questions from an audience of healthcare professionals on topics related to the management of patients with T-cell lymphomas including:

• Threshold of CD30 positivity useful to inform brentuximab vedotin use in patients with CTCL and PTCL
• Managing relapsed mycosis fungoides after allogeneic SCT
• Experience with ALK inhibition in ALCL with central nervous system metastases
• Managing refractory pruritus in CTCL
• Role of PI3K inhibitors in frontline and relapsed/refractory PTCL
• When to consider SCT in CTCL cycling through monotherapies

Presenters:

Steven M. Horwitz, MD
Member
Memorial Sloan Kettering Cancer Center
Attending Physician
Memorial Hospital
Professor of Medicine
Weill Cornell Medical College  
New York, New York

Francine Foss, MD
Professor of Medical Oncology
Yale Cancer Center
Yale University School of Medicine
New Haven, Connecticut

Barbara Pro, MD
Professor of Medicine
Division of Hematology/Oncology
Northwestern University
Chicago, Illinois

Link to the complete program, including downloadable slidesets, an expert commentary, and on-demand webcast, and healthcare professional resource guide:
https://bit.ly/3AKJE5s

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.